Skye Bioscience
Dr. Pasquale is the Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai in New York City.
He is a Phi Beta Kappa graduate of Manhattan College and earned his M.D. degree from SUNY Stony Brook where he was selected for Alpha Omega Alpha, the national honor medical society. Dr. Pasquale is Site Chair of the Department of Ophthalmology at Mt. Sinai Hospital and Vice-Chair of Translational Ophthalmology Research for the Mount Sinai Healthcare System. He currently serves as Glaucoma Trustee for the Association of Research in Vision and Ophthalmology (ARVO) and is a member of the National Institute of Health’s National Advisory Eye Council. He is a member of multiple editorial boards, including the Journal of Glaucoma, the American Journal of Ophthalmology, and Ophthalmology Glaucoma. Dr. Pasquale is an NIH Principal Investigator with continuous support since 2006.
This person is not in the org chart
This person is not in any offices
Skye Bioscience
Skye Bioscience (OTC: SKYE) is a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant unmet medical needs.